PDCD1 and neoplasm: Using the A20 lymphoma syngeneic mouse model, we treated tumor-bearing mice with vehicle, anti-PD1, high-dose AA, or the combination of high-dose AA and anti-PD1 (AA+anti-PD1) (Fig. 3A).